Description
Latin America high risk, order at your own risk (no free reship)
Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed. A study of the drug’s effects in mice was done in 1959. It concluded that at 50 mg/kg emylcamate gave a 63% decrease in motor activity compared with meprobamate’s 32% decrease, a doubling in effective potency.
Refund policy
Generally we offer our customers the choice between a partial/full refund or a reship depending on situation.
Please allow 24-48hours for a response to any complaints or concerns.
Example Cases:
1 Sending wrong product – Full refund if also active substance does not match.
2 Sending incorrect amount – Partial refund.
3 not like the product (very rare) – No refund.
4 Product is too weak – No refund – you have developed
Reviews
There are no reviews yet.